en · de · es · fr · pt
semaglutide-notes.peptides6823.com › Guide › �»“构特征与受体作用机制 — Background and Details

�»“构特征与受体作用机制 — Background and Details

By Editorial Desk · published 2026-01-16 · last reviewed 2026-02-07 · Guide

This is a working overview of lyophilization, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2026-02-07. Anything still debated is marked as such rather than presented as settled.

结构特征与受体作用机制

皮下注射后吸收相对缓慢,绝对生物利用度约为百分之八十九,血药浓度峰值通常出现在给药后一到三天。与白蛋白结合使清除减慢,终末半衰期约为一百六十五小时,接近一周。连续给药约四到五周后达到稳态暴露水平。表观分布容积约为每千克零点二五升,血浆蛋白结合率超过百分之九十九。代谢以蛋白水解切割和脂肪二酸侧链的 β-氧化为主,相关产物主要经尿液与粪便排出。

序列层面的改动同时解决了两个问题,即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟,主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库,使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发,属于该类药物化学改造的典型范式。

Handling, Storage, and Characterization

Semaglutide dissolves readily in water and in aqueous buffers near neutral pH. Solubility decreases near the isoelectric point, where net charge is minimal. Common laboratory solvents include phosphate-buffered saline and dilute ammonium bicarbonate. Strongly acidic or basic conditions may accelerate hydrolysis. Working concentrations are usually prepared by diluting a concentrated stock. Vial surfaces can adsorb small amounts of peptide at low concentrations, so carrier proteins or low-binding tubes are sometimes used.

Reverse-phase high-performance liquid chromatography is the standard method for purity assessment, separating the peptide from truncated or oxidized variants. Mass spectrometry confirms molecular mass and detects modifications, while ultraviolet absorbance near 280 nanometers supports concentration measurement through tryptophan and tyrosine residues. Circular dichroism can indicate secondary structure, though the peptide is largely helical in solution, and ion-exchange chromatography resolves charge variants. Purity values above 95 percent are typical for research-grade material. Stability studies track degradation over time under defined conditions.

Semaglutide at a glance

PropertyValueNotes
分子式C187H291N45O59按主链与 C18 二酸侧链计算
分子量约 4113.6 道尔顿游离碱形式,随反离子略有差异
外观白色至类白色冻干粉末具吸湿性,需干燥保存
溶解性微溶于水,易溶于碱性缓冲液溶解性随 pH 升高而改善
等电点约 5.4影响缓冲液选择与聚集倾向

Handling, Storage, and Analytical Verification

Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.

Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.

Related pages on this site

Handling, Storage, And Analytical Checks

Storage at minus 20 degrees Celsius or lower in a desiccated container preserves the peptide for extended periods, while working solutions are commonly held at two to eight degrees Celsius for short intervals. Light exposure and repeated freeze-thaw cycles accelerate degradation, so dividing material into single-use aliquots is generally recommended. Adsorption to glass and plastic surfaces can lower the measured concentration of dilute solutions, particularly below one milligram per millilitre. The degradation routes most often reported for GLP-1 analogues are deamidation, methionine oxidation, and backbone hydrolysis. Relative rates under specific conditions are frequently described only for individual formulations.

Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 or 280 nanometres is widely used to assess purity and to resolve related impurities. Liquid chromatography coupled to mass spectrometry confirms identity through the protonated molecular ion and fragment ions formed in tandem experiments. Capillary electrophoresis and peptide mapping after enzymatic digestion supply complementary information on charge variants and modification sites. Circular dichroism and nuclear magnetic resonance can report on secondary structure in solution. Absolute quantification usually depends on an external standard, and reported purity depends on the detection wavelength and integration parameters chosen.

Lyophilised material appears as a white to off-white cake or powder that is hygroscopic, and containers are usually equilibrated to room temperature before opening to limit condensation. Dissolution is performed in water, phosphate-buffered saline, or a mildly alkaline buffer, since solubility rises above neutral pH. Gentle inversion or low-speed mixing is preferred, because vigorous vortexing can promote surface denaturation and aggregation. Complete dissolution may require several minutes, and brief sonication is sometimes applied. Passing the solution through a 0.22 micrometre membrane removes particulates but does not by itself sterilise the liquid.

Background and Molecular Profile

Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.

The distinction between established facts and open questions matters here. That the peptide binds the GLP-1 receptor and stimulates insulin release in a glucose-dependent manner is well documented. How individual variability in receptor density, gastric emptying rate, and gut microbiome composition shapes response remains an active research area. Long-term outcomes beyond five years of continuous use are not yet fully characterized in published trials, and several extension studies are ongoing.

Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L cells after food intake. The molecule is a 31-amino-acid backbone modified at three positions to resist cleavage by dipeptidyl peptidase-4, the enzyme that degrades native GLP-1 within minutes. A lysine residue at position 26 carries a linker and a C18 fatty diacid, which promotes binding to serum albumin and slows renal clearance. These changes extend the circulating half-life from roughly two minutes to about one week in humans.

Peptide Background and Receptor Mechanism

The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.

Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.

Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released after nutrient intake. The molecule contains 31 amino acid residues and differs from the native sequence at several positions. A non-natural residue at position eight resists the enzyme that normally truncates the hormone, while a lysine-linked fatty diacid side chain promotes binding to serum albumin. These two modifications extend the circulating half-life from minutes to roughly one week. The peptide is produced by solid-phase synthesis followed by selective acylation, and its identity and purity are confirmed by spectrometric and chromatographic techniques.

Further detail

== United States usage == The Congress of the United States customarily adjourns a session sine die on the morning of January 3, immediately before the next session holds its constitutionally mandated first meeting. It can also adjourn sine die at other times through a concurrent resolution that allows the Speaker of the House and Senate Majority Leader to resume the session. State legislatures follow suit and mark adjournment sine die with a ceremony, such as the Connecticut General Assembly wherein, on the final day of the legislative session, the House and Senate meet in a joint convention, and the Secretary of the State recites "Oyez, Oyez, Oyez", pounds the gavel, and declares the legislature adjourned sine die. In the Florida Legislature, the sergeants-at-arms of the Florida Senate and the Florida House of Representatives step outside their chambers each holding a handkerchief. When they meet in between the chambers, they both drop the handkerchiefs, signifying the end of the legislative session.

The generation of reducing equivalents, in the form of NADPH, used in reductive biosynthesis reactions within cells (e.g. fatty acid synthesis). Production of ribose 5-phosphate (R5P), used in the synthesis of nucleotides and nucleic acids. Production of erythrose 4-phosphate (E4P), used in the synthesis of aromatic amino acids in non-mammals. Aromatic amino acids, in turn, are precursors for many biosynthetic pathways, including the lignin in wood. Dietary pentose sugars derived from the digestion of nucleic acids may be metabolized through the pentose phosphate pathway, and the carbon skeletons of dietary carbohydrates may be converted into glycolytic/gluconeogenic intermediates. In mammals, the PPP occurs exclusively in the cytoplasm. In humans, it is found to be most active in the liver, mammary glands, and adrenal cortex. The PPP is one of the three main ways the body creates molecules with reducing power, accounting for approximately 60% of NADPH production in humans. One of the uses of NADPH in the cell is to prevent oxidative stress. It reduces glutathione via glutathione reductase, which converts reactive H2O2 into H2O by glutathione peroxidase. If absent, the H2O2 would be converted to hydroxyl free radicals by Fenton chemistry, which can attack the cell. Erythrocytes, for example, generate a large amount of NADPH through the pentose phosphate pathway to use in the reduction of glutathione. Hydrogen peroxide is also generated for phagocytes in a process often referred to as a respiratory burst.

=== General references === anon, Guidance for Industry:Q8 (R2) Pharmaceutical Development, US FDA, 2009, [1] anon, Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics, May 1999, Food and Drug Administration, Center for Drug Evaluation and Research, [2] Lockhart, H., and Paine, F.A., "Packaging of Pharmaceuticals and Healthcare Products", 2006, Blackie, ISBN 0-7514-0167-6 Pilchik, R., "Validating Medical Packaging" 2002, ISBN 1-56676-807-1 Rosette, J. L, "Improving Tamper-Evident Packaging: Problems, Tests and Solutions", 1992 Soroka, W, "Fundamentals of Packaging Technology", IoPP, 2002, ISBN 1-930268-25-4 Soroka, W, Illustrated Glossary of Packaging Terminology, Institute of Packaging Professionals, [3] Yam, K. L., "Encyclopedia of Packaging Technology", John Wiley & Sons, 2009, ISBN 978-0-470-08704-6

== Products == In terms of molecular structure, one distinguishes first between low-molecular-weight (LMW) and high-molecular-weight (HMW) products. The generally accepted threshold between LMW and HMW is a molecular weight of about 700 g/mol. LMW fine chemicals, also designated as small molecules, are produced by traditional chemical synthesis, by microorganisms (through fermentation or biotransformation), or by extraction from plants and animals. In the production of modern life science products, total synthesis from petrochemicals prevails. HMW products, or large molecules, are obtained mainly through biotechnology processes. Within LMWs, the N-heterocyclic compounds are the most important category; within HMWs, it is peptides and proteins.

Sources: en.wikipedia.org

Supporting material

HIV infection In October 2016, scientists from Emory University and National Institute of Allergy and Infectious Diseases (NIAID) published a paper which claimed that they applied daily ART (antiretroviral therapy) of 90 days followed by simianized (rhesus macaques) anti α4β7 antibody on SIV+ rhesus macaques for 23 weeks. Twenty three months after stopping both ART and anti-α4β7 antibody treatment, the in vivo SIV level still remained undetectable. Therefore, treating HIV+ people with ART and anti-α4β7 simultaneously may be a new therapy that could potentially lead to an HIV infection cure. In mice, vedolizumab was not able to prevent or control HIV-infections. Phase 1 clinical trial of that therapy has been initialized by NIAID since May 2016. For each of the participants, they will get vedolizumab infusions every four weeks for 30 weeks. Before the 23rd week of vedolizumab infusions, cART (combination ART) is kept. During the 30 weeks, blood draws are repeated for baseline tests. After the 22-week-cART is stopped, both viral load and CD4 count will be monitored biweekly. If HIV viral load goes high or their CD4 cell counts decrease by too much when vedolizumab is used alone, cART will be brought back on the participants. The published results from this clinical trial suggest "that blockade of α4β7 may not be an effective strategy for inducing virological remission in HIV-infected individuals after ART interruption" because only one patient showed prolonged virus suppression.

=== AI Sovereignty and National Security (2026) === In April 2026, Technology Secretary Liz Kendall delivered a landmark speech at the Royal United Services Institute (RUSI), declaring that "control over where AI systems are built, how they operate and who ultimately controls them is now fundamental to economic security, energy security and defence security". The government announced plans to develop a UK AI hardware plan to secure Britain's capability in chips and semiconductor technologies, framing AI sovereignty not as isolationism but as ensuring the UK is "indispensable" in the global AI architecture. The government also established a Sovereign AI Fund. The fund is designed to invest directly in early-stage and growth-stage British AI companies, aiming to ensure the UK remains competitive in the global AI sector. the fund is managed by Suzanne Ashman.

1990 Thomas Jefferson Award from the University of Virginia Distinguished Alumni Award from the University of Minnesota Medical Alumni Association (2005) James D. Mills Award from the American College of Emergency Physicians (2008) Solomon A. Berson Award in Health Sciences from the New York University School of Medicine (2011).

Sources: en.wikipedia.org

Notes from published material

1930: Mexican civil engineer Concepción Mendizábal Mendoza became the first woman in Mexico to earn a civil engineering degree. 1930: Russian botanist and geneticist Elena Barulina published the first map of the international distribution of lentils and their wild relatives, a work that became the standard reference for researchers. 1932: Michiyo Tsujimura became the first Japanese woman to earn a doctorate in agriculture. She studied at the Tokyo Imperial University, and her doctoral thesis was entitled "On the Chemical Components of Green Tea". 1933: Hungarian scientist Elizabeth Rona received the Haitinger Prize from the Austrian Academy of Sciences for her method of extracting polonium. 1933: American bacteriologist Ruth Ella Moore became the first African-American woman to receive a PhD in the natural sciences, completing her doctorate in bacteriology at Ohio State University. 1933: Egyptian medical doctor Tawhida Abdel-Rahman became the first female doctor employed by the Egyptian Government Health Ministry. 1935: French chemist Irène Joliot-Curie received the Nobel Prize in Chemistry along with Frédéric Joliot-Curie "for their synthesis of new radioactive elements". 1935: American plant hybridist Grace Sturtevant, the "First Lady of Iris", received the American Iris Society's gold medal for her lifetime's work. 1936: American entomologist Edith Patch became the first female president of the Entomological Society of America. 1936: New Zealand mycologist Kathleen Maisey Curtis was elected the first female Fellow at the Royal Society of New Zealand.

Fard and Ugan Ali, who acknowledged leadership of the Allah Temple of Islam but vehemently denied any teaching of human sacrifice, were examined by psychiatrist David Clark, who recommended they be committed for further observation. A judge agreed, and both Fard and Ugan Ali were placed in straitjackets and confined in padded cells. With Fard and Ugan Ali still in custody five days after the murder, Elijah Muhammad, at the time known as Elijah Karriem, led over two hundred members into the court building and staged a protest on the main floor. The police spent a full day expelling the protesters.

=== Anti-inflammatory and analgesic agents === Glucocorticoids can be used in the short term and at the lowest dose possible for flare-ups and while waiting for slow-onset drugs to take effect. Combination of glucocorticoids and conventional therapy has shown a decrease in rate of erosion of bones. Steroids may be injected into affected joints during the initial period of RA, before the use of DMARDs or oral steroids. Non-NSAID drugs to relieve pain, like paracetamol may be used to help alleviate the pain symptoms; they do not change the underlying disease. The use of paracetamol may be associated with the risk of developing ulcers. NSAIDs reduce both pain and stiffness in those with RA but do not affect the underlying disease and appear to have no effect on people's long term disease course and thus are no longer first line agents. NSAIDs should be used with caution in those with gastrointestinal, cardiovascular, or kidney problems. Rofecoxib was withdrawn from the global market as its long-term use was associated to an increased risk of heart attacks and strokes. Use of methotrexate together with NSAIDs is safe, if adequate monitoring is done. COX-2 inhibitors, such as celecoxib, and NSAIDs are equally effective. A 2004 Cochrane review found that people preferred NSAIDs over paracetamol. However, it is yet to be clinically determined whether NSAIDs are more effective than paracetamol. The neuromodulator agents, topical capsaicin, may be reasonable to use in an attempt to reduce pain.

smooth automation and a relatively inexpensive plant was needed, easier to sterilize equipment and maintain a good manufacturing environment chromatographic processes are less damaging to the albumin protein a more successful albumin result can be achieved. Compared with the Cohn process, albumin purity increased from about 95% to 98% using chromatography, and the yield increased from about 65% to 85%. Small percentage increases make a difference in regard to sensitive measurements such as purity. The big drawback has to do with the economics. Although the method offered efficient, acquiring the necessary equipment was difficult. Large machinery is necessary, and for a long time, the lack of equipment availability limited its widespread use.

Sources: en.wikipedia.org

Frequently asked questions

Semaglutide 与天然 GLP-1 的主要差别是什么?

差别集中在三处:第 8 位残基被非天然氨基酸取代,第 34 位换成精氨酸,第 26 位增加一条脂肪酸侧链。前两处改动降低酶解速率,侧链则通过白蛋白结合延长循环时间。综合结果是半衰期从约两分钟延长到约一周。

受体激活后为何表现出葡萄糖依赖性?

胰岛素释放需要细胞内环腺苷酸与钙信号升高,同时依赖葡萄糖代谢产生的协同信号。血糖水平较低时协同信号不足,分泌增强有限。这一机制在降糖效果与低血糖风险之间提供了缓冲。

半衰期延长是否只归因于白蛋白结合?

白蛋白结合是主要原因,它减少肾小球滤过并保护分子免受蛋白酶降解。序列修饰带来的酶解抵抗同样不可忽略,二者共同作用。脂肪链的疏水性还会影响组织分布,但其对总半衰期的贡献程度仍在研究之中。

How should semaglutide powder be stored?

Long-term storage is usually at minus 20 to minus 80 degrees Celsius in a sealed, desiccated container. Working aliquots can be held briefly at 2 to 8 degrees Celsius.

Network